FUIL Trademark

Trademark Overview

On Wednesday, April 29, 2020, a trademark application was filed for FUIL with the United States Patent and Trademark Office. The USPTO has given the FUIL trademark a serial number of 88892946. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2024. This trademark is owned by Eli Lilly and Company. The FUIL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and Scientific Research in the field of oncology
fuil

General Information

Serial Number88892946
Word MarkFUIL
Filing DateWednesday, April 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Goods and ServicesMedical and Scientific Research in the field of oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 14, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Saturday, May 2, 2020NEW APPLICATION ENTERED
Thursday, May 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 8, 2020ASSIGNED TO EXAMINER
Friday, July 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 17, 2020NON-FINAL ACTION WRITTEN
Friday, July 17, 2020NON-FINAL ACTION E-MAILED
Friday, January 15, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 15, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 15, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Wednesday, August 18, 2021SOU EXTENSION 1 GRANTED
Wednesday, August 18, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, August 18, 2021SOU EXTENSION 1 FILED
Friday, March 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 23, 2022SOU EXTENSION 3 GRANTED
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021ASSIGNED TO EXAMINER
Wednesday, March 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 16, 2022SOU EXTENSION 2 FILED
Wednesday, March 16, 2022SOU EXTENSION 2 GRANTED
Friday, September 23, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 23, 2022SOU EXTENSION 3 FILED
Tuesday, September 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2023SOU EXTENSION 5 FILED
Monday, March 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 13, 2023SOU EXTENSION 4 FILED
Monday, March 13, 2023SOU EXTENSION 4 GRANTED
Wednesday, March 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 25, 2023SOU EXTENSION 5 GRANTED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, September 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

fuil oncology field research scientific medical